SV Health Investors

By supporting diverse entrepreneurs who create and build breakthrough companies and treatments

We empower innovators to improve patients’ lives.

And we have the track record to prove it

• $3

• 7B in historical commitments Global private equity and venture capital investment platform

• Specialized and diversified healthcare funds spanning all sectors and stages

• Five teams focused on biotechnology, dementia, healthcare growth equity, medtech and public equities

• View our Strategies Global private equity and venture capital investment platform Specialized and diversified healthcare funds spanning all sectors and stages Five teams focused on biotechnology, dementia, healthcare growth equity, medtech and public equities

• 75 IPOs/M&As Backing inspiring and talented innovators with diverse experiences to create healthcare industry leaders that attract strategic acquirers and public investors

• Our portfolio companies’ remarkable work benefits patients while growing shareholder value for investors

• View our Portfolio Backing inspiring and talented innovators with diverse experiences to create healthcare industry leaders that attract strategic acquirers and public investors Our portfolio companies’ remarkable work benefits patients while growing shareholder value for investors

• 28yrs track record in US and UK One of the longest-tenured healthcare investment managers in the world

• Experienced team of >55 investment professionals and operating partners based in Boston and London, adding value and guiding strategic direction

• Meet our People One of the longest-tenured healthcare investment managers in the world Experienced team of >55 investment professionals and operating partners based in Boston and London, adding value and guiding strategic direction

SV is driven by our talented team and network We bring together our experienced investment professionals with healthcare industry veterans to build value in breakthrough life sciences companies

The latest from SV

We're proud to share our achievements and those of our portfolio companies

• 25 JANUARY 2023 PORTFOLIO NEWS HPS/PayMedix Closes on $25 Million in New Funding

• 24 JANUARY 2023 Britain is losing its chance to become a life sciences superpower READ MORE

• 16 JANUARY 2023 SV NEWS British Patient Capital and Mubadala Invest in SV Biotech Crossover Opportunities Fund We invest in talented innovators We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you Please get in contact with our team

• Core SV Biotech Funds

• International Biotechnology Trust plc

• View all our Funds

• One Boston Place 201 Washington Street Suite 3900 Boston MA 02108 USA

• +1 617 367 8100

• +44 20 7421 7070 In the UK, SV Health Managers LLP (registered in England OC 308829, VAT 227 0451 34) is authorised and regulated by the Financial Conduct Authority ('FCA') It is entered into the FCA's register and with registration number 409119 The registered office is 71 Kingsway, London, WC2B 6ST

Shareholder Rights Directive (SRDII)
On 31st May 2019 the FCA issued their Policy Statement 19/13 (PS19/13) This made changes to the FCA Handbook to implement the requirements of the amended Shareholder Rights Directive established by the European Union The changes to the Handbook came into force on 10th June 2019 and introduced requirements for asset managers and insurers to publish details of their engagement policy

We are pleased to announce our Engagement Policy, a copy of which can be found here